Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Matinas Biopharma Holdings, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Matinas Biopharma Holdings, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Matinas Biopharma Holdings, Inc. since 2005.
The reporting company's ticker symbol is MTNB. The reporting company's CIK number is 1582554.
The total value of stock buying since 2005 is $294,500.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2017-09-11||Mannino Raphael J (Chief Scientific Officer)||Buy||5,000||1.41||7,050|
|2017-09-08||Rongen Roelof (Chief Executive Officer)||Buy||5,000||1.36||6,800|
|2017-09-08||Stern Adam K||Buy||50,000||1.38||69,000|
|2017-09-07||Stern Adam K||Buy||50,000||1.38||69,000|
|2017-09-07||Scibetta James S||Buy||5,000||1.29||6,450|
|2017-09-07||Conrad Herbert J||Buy||100,000||1.30||130,000|
Insider trading activities including stock purchases, stock sales, and option exercises of MTNB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Matinas Biopharma Holdings, Inc. (symbol MTNB, CIK number 1582554) see the Securities and Exchange Commission (SEC) website.